Back

Replimune says TUDRIQEV now available in U.S. for advanced melanoma

Verifying
  • Replimune announced TUDRIQEV is now available in the United States.
  • TUDRIQEV is available for advanced melanoma.
  • The announcement identifies the United States and advanced melanoma as the relevant market and condition.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.